Background
Banga, Ajay Kumar was born on November 1, 1960 in New Delhi, India. Came to the United States, 1985. Son of Madan L. and Parmesh (Gumbhir) Banga.
(Upon publication of the first edition of Therapeutic Pept...)
Upon publication of the first edition of Therapeutic Peptides and Proteins ten years ago there were only 19 biotechology medicines on the market. Currently there are more than 100, with at least 400 more in various stages of development. That alone would be grounds for a new edition. Add to that the fact that it is still difficult to find up-to-date, relevant information on protein formulation and/or delivery systems and the need for a new edition is self-evident. This second edition continues the tradition of providing a ready-to-use reference of accurate information, tables, and illustrations. The book begins with the basics of the origin of recombinant proteins, explores structural and analytical aspects, and moves on to discuss the stability of proteins and peptides. Against this background, the author addresses preformulation and formulation considerations and provides detailed information on important topics such as lyophilization. He goes on to discuss various delivery systems, including controlled release delivery systems and products currently on the market. The book also contains newly added regulatory information and thoroughly investigates therapeutic drugs made from proteins as well as protein-based vaccines. A new chapter on recombinant protein subunit vaccines and their delivery systems has been added. The work of a single author, the book provides complex information in a simple, elegant, and cohesive style. The author minimizes overlap between coverage and includes extensive cross-referencing that links related topics. Completely revised and updated, packed with cutting-edge information, the second edition once again fills the need for a reference that pulls all the relevant information together into one resource.
http://www.amazon.com/gp/product/0849316308/?tag=2022091-20
( There are more than 500 biopharmaceuticals on the marke...)
There are more than 500 biopharmaceuticals on the market, including more than 200 therapeutic proteins, making biologics the fastest growing sector in the biopharmaceutical market. These products include more than 40 monoclonal antibodies, for indications ranging from treatment or mitigation of various types of cancer to rheumatoid arthritis. The clinical application of these therapeutic peptides and proteins is limited by several problems, such as lack of physical and chemical stability or the lack of desirable attributes for adequate absorption or distribution. Thus, as these therapeutic peptides and proteins are made available, it will be essential to formulate these drugs into safe, stable, and efficacious delivery systems. The pharmaceutical scientist involved in this effort needs to call upon the knowledge of several disciplines, such as pharmaceutics, medicinal chemistry, biochemistry, microbiology, and chemical engineering and needs to keep abreast with the latest research in the published literature. Therapeutic Peptides and Proteins: Formulation, Processing, and Delivery Systems, Third Edition provides a comprehensive overview of the field for scientists in industry and academia and for students, while also providing practical information on the challenges facing the formulation and delivery aspects of these unique macromolecules. In particular, the book: • Explains how recombinant DNA techniques now allow us to produce therapeutic proteins in a commercially viable form • Discusses the physical and chemical pathways of peptide and protein degradation • Includes a detailed discussion of protein formulation and lyophilization • Overviews the pharmacokinetic aspects of therapeutic peptides and proteins and discusses controlled delivery systems for parenteral administration, including microsphere formulations • Discusses research progress on oral, transdermal, mucosal, and topical delivery systems discusses transdermal and topical delivery
http://www.amazon.com/gp/product/146656606X/?tag=2022091-20
http://www.amazon.com/gp/product/B010WFEHXS/?tag=2022091-20
Banga, Ajay Kumar was born on November 1, 1960 in New Delhi, India. Came to the United States, 1985. Son of Madan L. and Parmesh (Gumbhir) Banga.
Bachelor of Pharmaceutical, University Delhi, 1981. Master of Pharmaceutical, University Delhi, 1983. Master of Science, University Oklahoma, 1986.
Doctor of Philosophy, Rutgers University, 1990.
Research scientist, Ranbaxy laboratories, Ltd., New Delhi, India, 1983-1985; formulation scientist, Bausch & Lomb, Rochester, New York, 1990-1991; assistant professor, Auburn (Alabama) U., 1991-1996; associate professor, Auburn (Alabama) U., since 1996.
( There are more than 500 biopharmaceuticals on the marke...)
(Upon publication of the first edition of Therapeutic Pept...)
Member American Association Pharmaceutical Scientists (chair committee since 1994), Alabama Academy of Sciences, Controlled Release Society, Sigma Xi.
Married Saveta Dube, December 12, 1989.
